Qu’avons-nous compris en 20 ans sur la polyradiculoneuropathie inflammatoire démyélinisante chronique ? [What have we learned about chronic inflammatory demyelinating polyradiculoneuropathyin the last twenty years ?]

Details

Ressource 1Download: RMS_779_808.pdf (157.52 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_B256E36DFA3E
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Qu’avons-nous compris en 20 ans sur la polyradiculoneuropathie inflammatoire démyélinisante chronique ? [What have we learned about chronic inflammatory demyelinating polyradiculoneuropathyin the last twenty years ?]
Journal
Revue medicale suisse
Author(s)
Magy L., Echaniz-Laguna A., Fayolle D., Hübers A., Ochsner F., Vicino A., Théaudin M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
27/04/2022
Peer-reviewed
Oui
Volume
18
Number
779
Pages
808-812
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) has been widely described during the last quarter of the twentieth century. The last 20 years have seen decisive progress in its understanding. The diagnostic criteria have been simplified and the steps of the diagnostic process have been clarified. The phenotypic contours of the disease are now well known, as are the diagnostic pitfalls. From a pathophysiological point of view, the discovery of autoantibodies directed against nodal and paranodal proteins has been a major advance, although it concerns only a minority of patients. These discoveries have a major impact on the therapeutic management of these patients, often suffering from a very active form of the disease. The next 20 years will surely see a further deepening of knowledge about this fascinating disease.
Keywords
Autoantibodies, Humans, Inflammation, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/diagnosis, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/therapy
Pubmed
Create date
16/05/2022 9:54
Last modification date
17/08/2022 6:13
Usage data